 <h1>Koselugo Side Effects</h1><p class="drug-subtitle"><b>Generic Name:</b> <i>selumetinib</i></p><ul class="ddc-anchor-links"><li>Consumer</li>
<li>Professional</li></ul><p class="ddc-notification"><b>Note:</b> This document contains side effect information about selumetinib. Some of the dosage forms listed on this page <em>may not</em> apply to the brand name Koselugo.</p><h2 class="ddc-anchor-offset" id="consumer">For the Consumer</h2><p><i>Applies to selumetinib: oral capsule</i></p><h3>Warning</h3><p>Follow all directions on your medicine label and package. Tell each of your healthcare providers about all your medical conditions, allergies, and all medicines you use.</p><p>Get emergency medical help if you have signs of an allergic reaction:  hives; difficult breathing; swelling of your face, lips, tongue, or throat.</p><p>Call your doctor at once if you have:</p><ul>
<li>
<p>severe or ongoing diarrhea;</p>
</li>
<li>
<p>a skin rash with blistering or peeling, or any rash that covers a large area of skin;</p>
</li>
<li>
<p>heart problems--tiredness, fast heartbeats, cough, wheezing, shortness of breath, swelling in your lower legs;</p>
</li>
<li>
<p>vision changes--blurred vision, vision loss, seeing dark spots or "floaters" in your vision;  </p>
</li>
<li>
<p>unexplained muscle pain, tenderness, or weakness (especially if you also have fever, unusual tiredness, or dark colored urine).</p>
</li>
</ul><p>severe or ongoing diarrhea;</p><p>a skin rash with blistering or peeling, or any rash that covers a large area of skin;</p><p>heart problems--tiredness, fast heartbeats, cough, wheezing, shortness of breath, swelling in your lower legs;</p><p>vision changes--blurred vision, vision loss, seeing dark spots or "floaters" in your vision;  </p><p>unexplained muscle pain, tenderness, or weakness (especially if you also have fever, unusual tiredness, or dark colored urine).</p><p>Diarrhea is a common side effect of this medicine. Tell your doctor right away the first time you have diarrhea while taking selumetinib (the active ingredient contained in Koselugo) </p><p>Your doses may be delayed or permanently discontinued if you have certain side effects.</p><p>Common side effects may include:</p><ul>
<li>
<p>nausea, vomiting, stomach pain;</p>
</li>
<li>
<p>itching;</p>
</li>
<li>
<p>dry skin, acne, rash;</p>
</li>
<li>
<p>redness around your fingernails;</p>
</li>
<li>
<p>feeling weak or tired;</p>
</li>
<li>
<p>mouth pain or soreness, swollen gums;</p>
</li>
<li>
<p>muscle or bone pain;</p>
</li>
<li>
<p>headache; or</p>
</li>
<li>
<p>fever.</p>
</li>
</ul><p>nausea, vomiting, stomach pain;</p><p>itching;</p><p>dry skin, acne, rash;</p><p>redness around your fingernails;</p><p>feeling weak or tired;</p><p>mouth pain or soreness, swollen gums;</p><p>muscle or bone pain;</p><p>headache; or</p><p>fever.</p><p>This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. </p><h2 class="ddc-anchor-offset" id="professional">For Healthcare Professionals</h2><p><i>Applies to selumetinib: oral capsule</i></p><h3>Hematologic</h3><p><b>Very common</b> (10% or more): Hemoglobin decreased (41%), neutrophils decreased (33%), lymphocytes decreased (20%)</p><p><b>Frequency not reported</b>: Increased vitamin E causing increased bleeding<sup>[Ref]</sup></p><h3>Musculoskeletal</h3><p><b>Very common</b> (10% or more): Creatinine phosphokinase (CPK) increased (79%), musculoskeletal pain (e.g., pain in extremity, back pain, neck pain, musculoskeletal pain) (58%)<sup>[Ref]</sup></p><h3>Ocular</h3><p><b>Very common</b> (10% or more): Blurred vision, photophobia, cataracts, and ocular hypertension (15%), visual impairment</p><p><b>Frequency not reported</b>: Retinal vein occlusion (RVO), retinal pigment epithelial detachment (RPED)<sup>[Ref]</sup></p><h3>Metabolic</h3><p><b>Very common</b> (10% or more): Albumin decreased (79%), anorexia (22%), increased/decreased potassium (18%), amylase increased (18%), sodium increased (18%), sodium decreased (16%), weight increased<sup>[Ref]</sup></p><h3>Genitourinary</h3><p><b>Very common</b> (10% or more): Hematuria (22%), proteinuria (22%)<sup>[Ref]</sup></p><h3>Hepatic</h3><p><b>Very common</b> (10% or more): AST increased (41%), ALT increased (35%), alkaline phosphatase increased (18%), acute kidney injury<sup>[Ref]</sup></p><h3>Respiratory</h3><p><b>Very common</b> (10% or more): Epistaxis (28%), dyspnea (e.g., exertional dyspnea, dyspnea at rest)<sup>[Ref]</sup></p><h3>Other</h3><p><b>Very common</b> (10% or more): Fatigue/malaise (56%), pyrexia (56%), edema (e.g., peripheral swelling, edema, localized edema) (20%), edema (e.g., periorbital edema, face edema)<sup>[Ref]</sup></p><h3>General</h3><p>The most common adverse reactions (40% or greater) were vomiting, rash (all), abdominal pain, diarrhea, nausea, dry skin, fatigue, musculoskeletal pain, pyrexia, acneiform rash, stomatitis, headache, paronychia, and pruritus.<sup>[Ref]</sup></p><h3>Nervous system</h3><p><b>Very common</b> (10% or more): Headache (48%)<sup>[Ref]</sup></p><h3>Cardiovascular</h3><p><b>Very common</b> (10% or more): Cardiomyopathy (decrease in left ventricular ejection fraction [LVEF] greater than or equal to 10% below baseline) (22%), sinus tachycardia (20%), hypertension<sup>[Ref]</sup></p><h3>Dermatologic</h3><p><b>Very common</b> (10% or more): Rash (e.g., dermatitis acneiform, rash maculopapular, erythema, rash pustular, urticaria, exfoliative rash, rash pruritic, rash erythematous, eczema) (91%), dry skin (60%), rash acneiform (dermatitis acneiform) (50%), paronychia (e.g., paronychia, nail infection) (48%), pruritus (46%), dermatitis (e.g., dermatitis, dermatitis atopic, dermatitis diaper, eczema, seborrheic dermatitis, skin irritation) (36%), hair changes (e.g., alopecia, hair color change) (32%)</p><p><b>Frequency not reported</b>: Palmar-plantar erythrodysesthesia syndrome<sup>[Ref]</sup></p><h3>Gastrointestinal</h3><p><b>Very common</b> (10% or more): Vomiting (82%), abdominal pain (76%), diarrhea (70%), nausea (66%), stomatitis (e.g., stomatitis, mouth ulceration) (50%), constipation (34%), lipase increased (32%), dry mouth, GI perforation, colitis, ileus, intestinal obstruction<sup>[Ref]</sup></p><p id="ref_1">1. "Product Information. Koselugo (selumetinib)." Astra-Zeneca Pharmaceuticals, Wilmington, DE. </p><h2>More about Koselugo (selumetinib)</h2><ul class="more-resources-list more-resources-list-general">
<li>During Pregnancy</li>
<li>Dosage Information</li>
<li>Drug Images</li>
<li>Drug Interactions</li>
<li>Pricing &amp; Coupons</li>
<li>En Espa√±ol</li>
<li>Drug class: multikinase inhibitors</li>
<li>FDA Approval History</li>
</ul><h3>Consumer resources</h3><ul class="more-resources-list more-resources-list-consumer">
<li>Patient Information</li>
<li>Koselugo &lt;span&gt;(Advanced Reading)&lt;/span&gt;</li>
</ul><h3>Professional resources</h3><ul class="more-resources-list more-resources-list-professional">
<li>Prescribing Information</li>
<li data-more-config-id="list-data-resources-professional">... +1 more</li>
</ul><h3>Related treatment guides</h3><ul class="more-resources-list more-resources-list-conditions">
<li>Neurofibromatosis</li>
</ul><h2>Further information</h2><p class="ddc-disclaimer">Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.</p><p>Some side effects may not be reported. You may report them to the FDA.</p><p class="ddc-disclaimer-link">Medical Disclaimer</p>